Should a diagnosis of cancer impact the anticoagulant therapy in patients with recurrent thromboembolic disease?
Journal Title: OncoReview - Year 2015, Vol 5, Issue 2
Abstract
Venous thromboembolism often coexists with cancer, deteriorating patient prognosis. The diagnosis of cancer in patients who suffer from venous thromboembolism may lead to changes in the anticoagulant therapy administered. We present a case report involving a 72-year-old patient with recurrent venous thromboembolism and chronic thromboembolic pulmonary hypertension in whom the diagnosis of colorectal cancer resulted in the need for modification of the anticoagulant therapy. Oral anticoagulant was replaced with low molecular weight heparin and an inferior vena cava filter was implanted due to active bleeding from the anus, high perioperative risk of bleeding, which caused the need for a temporary interruption of anticoagulant therapy.
Authors and Affiliations
Maria Wieteska, Marcin Kurzyna, Sebastian Szmit, Adam Torbicki
Keywords
Related Articles
- EP ID EP67781
- DOI -
- Views 207
- Downloads 0
Pericardial effusion endangering cardiac tamponade in cases of patients suffering for malignant diseases – diagnostics and management
Pericardial effusion endangering cardiac tamponade is a condition of high risk of life loss. In case of endangering cardiac tamponade the most important are: fast diagnosis, pericardiocentesis and drainage of the pericar...
Steroid-induced diabetes in oncology
Patients with neoplasms belong to the group of higher risk for developing steroid-induced diabetes. The rules of diagnosis of this form of diabetes do not differ from others of its type, but the course and treatment diff...
Everolimus in clinical practice. Review of German non-interventional study of everolimus in metastatic renal cell cancer after failure of initial tyrosine kinase inhibitor therapy
Everolimus is a standard for treatment of anti-vascular endothelial growth factor (VEGF)-refractory patients with metastatic renal cell carcinoma (mRCC). A German study documented mRCC patient treated everolimus from 79...
The role of granulocyte colony-stimulating factors in the prevention of neutropenia and febrile neutropenia – the current state of knowledge
Granulocyte colony-stimulating factors, introduced in the 1990s to prevent neutropenic fever, improve patients’ prognosis after myelotoxic chemotherapy. G-CSFs accelerate bone marrow recovery, shortening the duration of...
New integrative PDT method of cancer treatment by means of laser, magnetic therapy and herbal ferromagnetics
Integrative photodynamic therapy (IPDT) of tumors consists of combined use of different curable factors that extremely increase the effectiveness of IPDT. The leading curable effect of PDT is determined by developing of...